A living, synthetic cell has been made by transplanting a complete genome into a dead bacterium, bringing it back to life. The breakthrough could help synthetic biology live up to its huge, but still ...

I was two years old when I was diagnosed with sickle cell HbSC disease. By age 10, I had already survived four surgeries. I don’t remember a life without this disease — without the hospitalizations, ...

For years, one of the most powerful weapons against certain blood cancers, called CAR-T therapy, has required an elaborate process: Doctors extract a patient’s immune cells, ship them to a specialized ...

In 2022, the team at Cortical Labs taught 800,000 brain cells in a petri dish connected to a computer how to play the 1970s game Pong. Now, years later, the same team is leveling up as they claim ...

A pair of new studies have provided fresh evidence in the long-running scientific debate—and the result could be game-changing for treating diseases like Alzheimer’s and dementia. For decades ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. In 2022 ...

I went to federal prison for contempt of Congress. My detractors say I acted above the law. My supporters say I’m the poster child for a weaponized justice system. I won’t relitigate that here. What ...

Why some people recover more quickly from pain may come down to hormone levels. andreswd/E+ via Getty Images Pain is something most people experience after an injury, whether from a sprained ankle, ...

Why health influencers are obsessed with mitochondria. By Dana G. Smith Last summer, Health Secretary Robert F. Kennedy Jr. said he could tell that someone was having “mitochondrial challenges” just ...

Let’s say it’s 2036, and scientists are working on a new class of drugs. These medications are mirror-image versions of the molecules your body uses to fight disease. Their big advantage is that ...

CD7 is an attractive target for chimeric antigen receptor (CAR) T-cell therapy in relapsed or refractory T-cell acute lymphoblastic leukemia (ALL). Supportive results of first-in-human studies of base ...